To keep the global research community and research product suppliers informed on the continuing impact of the COVID-19 pandemic on research efforts Percepta fielded the first COVID-19 Impact survey on April 3, 2020.  This survey was re-fielded, with the addition of several questions, on May 1, 2020 and once more on June 1, 2020.

CRISPR technology is a simple yet powerful tool for editing genomes. It allows researchers to easily alter DNA sequences and modify gene function. Its many potential applications include correcting genetic defects, treating and preventing the spread of diseases and improving crops. As life science suppliers continue to improve products and services the CRISPR gene/genome editing market, represents a significant…

The first version of this Pulse Report was published in early April 2020.  As the COVID-19 pandemic continues to take its toll on research programs across academia and pharma/biotech globally we are providing this updated complimentary report from Percepta has been provided to help you stay informed on the pandemic’s current impact on laboratory closures, funding, headcount, project changes,…

As the COVID-19 pandemic takes its toll on research programs
across academia and pharma/biotech we are in turn interested to better
understand the current research landscape and how we can best support it.

On April 3, 2020 we fielded a brief survey to the Percepta panel of life scientists. We received 1,015 completed surveys from around the globe.  Key findings from the…